165 related articles for article (PubMed ID: 35163478)
1. Different Expression Levels of DLK2 Inhibit NOTCH Signaling and Inversely Modulate MDA-MB-231 Breast Cancer Tumor Growth In Vivo.
Naranjo AI; González-Gómez MJ; Baladrón V; Laborda J; Nueda ML
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163478
[TBL] [Abstract][Full Text] [Related]
2. Different expression levels of DLK1 inversely modulate the oncogenic potential of human MDA-MB-231 breast cancer cells through inhibition of NOTCH1 signaling.
Nueda ML; Naranjo AI; Baladrón V; Laborda J
FASEB J; 2017 Aug; 31(8):3484-3496. PubMed ID: 28461338
[TBL] [Abstract][Full Text] [Related]
3. The EGF-like proteins DLK1 and DLK2 function as inhibitory non-canonical ligands of NOTCH1 receptor that modulate each other's activities.
Sánchez-Solana B; Nueda ML; Ruvira MD; Ruiz-Hidalgo MJ; Monsalve EM; Rivero S; García-Ramírez JJ; Díaz-Guerra MJ; Baladrón V; Laborda J
Biochim Biophys Acta; 2011 Jun; 1813(6):1153-64. PubMed ID: 21419176
[TBL] [Abstract][Full Text] [Related]
4. A truncated-Flt1 isoform of breast cancer cells is upregulated by Notch and downregulated by retinoic acid.
Mezquita B; Mezquita J; Barrot C; Carvajal S; Pau M; Mezquita P; Mezquita C
J Cell Biochem; 2014 Jan; 115(1):52-61. PubMed ID: 23904188
[TBL] [Abstract][Full Text] [Related]
5. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
6. Notch activation stimulates migration of breast cancer cells and promotes tumor growth.
Bolós V; Mira E; Martínez-Poveda B; Luxán G; Cañamero M; Martínez-A C; Mañes S; de la Pompa JL
Breast Cancer Res; 2013; 15(4):R54. PubMed ID: 23826634
[TBL] [Abstract][Full Text] [Related]
7. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
[TBL] [Abstract][Full Text] [Related]
8. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231.
Gao Y; Ge Z; Zhang Z; Bai Z; Ma X; Wang Y
Chin Med J (Engl); 2014; 127(10):1947-53. PubMed ID: 24824261
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
[TBL] [Abstract][Full Text] [Related]
12. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.
Matsuda Y; Schlange T; Oakeley EJ; Boulay A; Hynes NE
Breast Cancer Res; 2009; 11(3):R32. PubMed ID: 19473496
[TBL] [Abstract][Full Text] [Related]
13. Delta-like 2 negatively regulates chondrogenic differentiation.
Xu W; Wang Y; Zhao H; Fan B; Guo K; Cai M; Zhang S
J Cell Physiol; 2018 Sep; 233(9):6574-6582. PubMed ID: 29057471
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
Zhu L; Zhang S; Huan X; Mei Y; Yang H
Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
[TBL] [Abstract][Full Text] [Related]
16. Delta like Non-Canonical Notch Ligand 2 inhibits chondrogenic differentiation and cell proliferation of bone marrow mesenchymal stem cells through the Notch1 signaling pathway.
Chen Y; Liu Y; Zhang R; Mao Y; He A; Liu W
Tissue Cell; 2023 Dec; 85():102220. PubMed ID: 37776784
[TBL] [Abstract][Full Text] [Related]
17. The proteins DLK1 and DLK2 modulate NOTCH1-dependent proliferation and oncogenic potential of human SK-MEL-2 melanoma cells.
Nueda ML; Naranjo AI; Baladrón V; Laborda J
Biochim Biophys Acta; 2014 Nov; 1843(11):2674-84. PubMed ID: 25093684
[TBL] [Abstract][Full Text] [Related]
18. Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway.
Adams LS; Phung S; Yee N; Seeram NP; Li L; Chen S
Cancer Res; 2010 May; 70(9):3594-605. PubMed ID: 20388778
[TBL] [Abstract][Full Text] [Related]
19. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
20. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways.
Maroufi NF; Vahedian V; Akbarzadeh M; Mohammadian M; Zahedi M; Isazadeh A; Pouremamali F; Taefehshokr S; Heidari M; Rashidi M; Nouri M
Breast Cancer; 2020 Jul; 27(4):613-620. PubMed ID: 32026267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
